Company Filing History:
Years Active: 2021
Title: Te-Hsien Kung: Innovator in Protein Aggregate Research
Introduction
Te-Hsien Kung is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the treatment of diseases associated with abnormal protein aggregates. His innovative work has the potential to impact the understanding and management of neurodegenerative diseases.
Latest Patents
Te-Hsien Kung holds a patent for "Bipartite molecules and uses thereof in treating diseases associated with abnormal protein aggregates." This patent describes bipartite molecules that comprise a peptide affinity moiety and at least one charged moiety. These molecules are designed to reduce the formation of abnormal protein aggregates and treat diseases characterized by such aggregates, including neurodegenerative diseases.
Career Highlights
Te-Hsien Kung is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to engage in cutting-edge research and contribute to advancements in the field of protein aggregation and its implications for health.
Collaborations
Te-Hsien Kung collaborates with esteemed colleagues, including Benjamin Pang-Hsien Tu and Rita Py Chen. Their combined expertise enhances the research efforts in addressing complex biomedical challenges.
Conclusion
Te-Hsien Kung's innovative research and patent contributions are paving the way for new treatments for diseases linked to protein aggregates. His work exemplifies the importance of scientific innovation in improving health outcomes.